Chemistry:GW-788,388

From HandWiki
Short description: Synthetic compound
GW-788,388
GW788388 structure.png
Identifiers
CAS Number
PubChem CID
Chemical and physical data
FormulaC25H23N5O2
Molar mass425.492 g·mol−1
3D model (JSmol)

GW 788388 is a synthetic compound which acts as a potent and selective inhibitor for TGF beta receptor 1.[1] It has applications in research into various disorders such as liver, kidney and heart disease (especially associated with Chagas disease),[2][3][4][5][6][7] and potential antiviral properties.[8]

See also

References

  1. "Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor". Journal of Medicinal Chemistry 49 (7): 2210–2221. April 2006. doi:10.1021/jm0509905. PMID 16570917. 
  2. "Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease". PLOS Neglected Tropical Diseases 6 (6): e1696. 2012. doi:10.1371/journal.pntd.0001696. PMID 22720109. 
  3. "The TGFβ1 Receptor Antagonist GW788388 Reduces JNK Activation and Protects Against Acetaminophen Hepatotoxicity in Mice". Toxicological Sciences 170 (2): 549–561. May 2019. doi:10.1093/toxsci/kfz122. PMID 31132129. 
  4. "Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis". Kidney International 73 (6): 705–715. March 2008. doi:10.1038/sj.ki.5002717. PMID 18075500. 
  5. "Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction". American Journal of Physiology. Heart and Circulatory Physiology 298 (5): H1415–H1425. May 2010. doi:10.1152/ajpheart.01048.2009. PMID 20154262. 
  6. "TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease". PLOS Neglected Tropical Diseases 13 (7): e0007602. July 2019. doi:10.1371/journal.pntd.0007602. PMID 31365537. 
  7. "Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells". International Journal of Molecular Sciences 22 (9): 4739. April 2021. doi:10.3390/ijms22094739. PMID 33947038. 
  8. "Suppression of TGF-β/Smad2 signaling by GW788388 enhances DENV-2 clearance in macrophages". Journal of Medical Virology 94 (9): 4359–4368. September 2022. doi:10.1002/jmv.27879. PMID 35596058.